CN Patent

CN117683036A — 一种含氮杂环化合物、其药物组合物及应用

Assigned to Shanghai Yingli Pharmaceutical Co Ltd · Expires 2024-03-12 · 2y expired

What this patent protects

本发明公开了一种含氮杂环化合物、其药物组合物及应用。本发明的含氮杂环化合物的结构如式I所示。本发明的含氮杂环化合物对PI3K介导的多种疾病细胞均有较佳的抑制作用，有望治疗和/或预防由PI3K介导的多种疾病。

USPTO Abstract

本发明公开了一种含氮杂环化合物、其药物组合物及应用。本发明的含氮杂环化合物的结构如式I所示。本发明的含氮杂环化合物对PI3K介导的多种疾病细胞均有较佳的抑制作用，有望治疗和/或预防由PI3K介导的多种疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN117683036A
Jurisdiction
CN
Classification
—
Expires
2024-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Yingli Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.